Renaissance IPO ETF
IPODividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 19, 2025 | $0.18 | 2025-09-12 | 2025-09-12 |
| June 20, 2025 | $0.05 | 2025-06-13 | 2025-06-13 |
| March 21, 2025 | $0.07 | 2025-03-14 | 2025-03-14 |
| December 20, 2024 | $0.03 | 2024-12-13 | 2024-12-13 |
| September 20, 2024 | $0.01 | 2024-09-13 | 2024-09-13 |
Dividends Summary
- Consistent Payer: Renaissance IPO ETF has rewarded shareholders with 27 dividend payments over the past 12 years.
- Total Returned Value: Investors who held IPO shares during this period received a total of $1.53 per share in dividend income.
- Latest Payout: The most recent dividend of $0.18/share was paid 126 days ago, on September 19, 2025.
- Yield & Schedule: IPO currently pays dividends quarterly with an annual yield of 0.71%.
- Dividend Growth: Since 2013, the dividend payout has grown by 1033.5%, from $0.02 to $0.18.
Company News
The U.S. IPO market is experiencing renewed activity in January 2026 with 20+ offerings launched or scheduled. Notable companies going public include BitGo Holdings, Aigo Holding Limited, Riku Dining Group Limited, EquipmentShare.com, Ethos Technologies, PicS N.V., and York Space Systems. IPO-focused ETFs are gaining investor attention as tools t...
The U.S. IPO market is experiencing a strong revival in 2025, with 163 companies going public and raising $31 billion, driven by a favorable business climate under President Trump's second term and increased investor risk appetite.
Q3 2025 IPO filings have reached 104, marking the strongest quarter since Q1 2022. Several companies like Klarna, StubHub, and Netskope are going public, driven by anticipated Fed rate cuts and strong stock market performance.
Activist investor Dan Loeb's Third Point LLC acquired a significant stake in consumer health company Kenvue, making it one of his top five holdings. Kenvue updated its fiscal 2025 outlook, and its Q1 sales beat consensus.
Hinge Health, a provider of wearable devices for musculoskeletal health, filed for an IPO to raise up to $500 million. The company reported a 33% revenue increase in 2024 and narrowed its net losses.
